Your browser doesn't support javascript.
High D dimers and low global fibrinolysis coexist in COVID19 patients: what is going on in there?
Ibañez, C; Perdomo, J; Calvo, A; Ferrando, C; Reverter, J C; Tassies, D; Blasi, A.
  • Ibañez C; Anesthesia Department, Hospital Clinic de Barcelona, Barcelona, Spain.
  • Perdomo J; Anesthesia Department, Hospital Clinic de Barcelona, Barcelona, Spain.
  • Calvo A; Anesthesia Department, Hospital Clinic de Barcelona, Barcelona, Spain.
  • Ferrando C; Anesthesia Department, Hospital Clinic de Barcelona, Barcelona, Spain.
  • Reverter JC; Hemostasis Department, IDIBAPS, Hospital Clinic de Barcelona, Barcelona, Spain.
  • Tassies D; Hemostasis Department, IDIBAPS, Hospital Clinic de Barcelona, Barcelona, Spain.
  • Blasi A; Anesthesia Department, IDIBAPS, Hospital Clinic de Barcelona, Barcelona, Spain. ablasi@clinic.cat.
J Thromb Thrombolysis ; 51(2): 308-312, 2021 Feb.
Article in English | MEDLINE | ID: covidwho-645217
ABSTRACT
BACKGROUD COVID-19 coagulopathy linked to increased D-dimer levels has been associated with high mortality (Fei Z et al. in Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China a retrospective cohort study. Lancet (London, England) 395(10229)1054-62, 2020). While D-dimer is accepted as a disseminated intravascular coagulation marker, rotational thromboelastometry (ROTEM) also detects fibrinolysis (Wright FL et al. in Fibrinolysis shutdown correlates to thromboembolic events in severe COVID-19 infection. J Am Coll Surg (2020). Available from https//pubmed.ncbi.nlm.nih.gov/32422349/ [cited 14 Jun 2020]; Schmitt FCF et al. in Acute fibrinolysis shutdown occurs early in septic shock and is associated with increased morbidity and mortality results of an observational pilot study. Ann Intensive Care 9(1)19, 2019). We describe the ROTEM profile in severely ill COVID-19 patients and compare it with the standard laboratory coagulation test.

METHODS:

Adult patients diagnosed with COVID-19 admitted to the ICU were prospectively enrolled after Ethics Committee approval (HCB/2020/0371). All patients received venous thromboembolism prophylaxis; those on therapeutic anticoagulation were excluded. The standard laboratory coagulation test and ROTEM were performed simultaneously at 24-48 h after ICU admission. Sequential organ failure assessment (SOFA), disseminated intravascular coagulation (DIC) and sepsis-induced coagulopathy (SIC) scores were calculated at sample collection.

RESULTS:

Nineteen patients were included with median SOFA-score of 4 (2-6), DIC-score of 1 (0-3) and SIC-score of 1.8 (0.9). Median fibrinogen, D-dimer levels and platelet count were 6.2 (4.8-7.6 g/L), 1000 (600-4200 ng/ml) and 236 (136-364 109/L), respectively. Clot firmness was above the normal range in the EXTEM and FIBTEM tests while clot lysis was decreased. There was no significant correlation between ROTEM or D-dimer parameters and the SOFA score.

CONCLUSION:

In COVID-19 patients, the ROTEM pattern was characterized by a hypercoagulable state with decreased fibrinolytic capacity despite a paradoxical increase in D-dimer levels. We suggest that, in COVID-19 patients, the lungs could be the main source of D-dimer, while a systemic hypofibrinolytic state coexists. This hypothesis should be confirmed by future studies.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Thromboembolism / Fibrin Fibrinogen Degradation Products / Fibrinolysis / SARS-CoV-2 / COVID-19 / COVID-19 Drug Treatment / Anticoagulants Type of study: Cohort study / Observational study / Prognostic study Limits: Aged / Female / Humans / Male / Middle aged Language: English Journal: J Thromb Thrombolysis Journal subject: Vascular Diseases Year: 2021 Document Type: Article Affiliation country: S11239-020-02226-0

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Thromboembolism / Fibrin Fibrinogen Degradation Products / Fibrinolysis / SARS-CoV-2 / COVID-19 / COVID-19 Drug Treatment / Anticoagulants Type of study: Cohort study / Observational study / Prognostic study Limits: Aged / Female / Humans / Male / Middle aged Language: English Journal: J Thromb Thrombolysis Journal subject: Vascular Diseases Year: 2021 Document Type: Article Affiliation country: S11239-020-02226-0